Gifford David R. 4

What Happened
David R. Gifford, a director of National Healthcare Corp (NHC), was granted 7,500 derivative securities on May 7, 2026. The Form 4 reports the acquisition price as $0.00, indicating these are option awards (not an open-market purchase) and no cash was paid at grant. The filing does not state a dollar value or the option exercise price in the provided excerpt.

Key Details

• Transaction date: 2026-05-07; Transaction type: Award/Grant (code A) of derivative securities (stock options).
• Amount: 7,500 options granted; acquisition price shown as $0.00.
• Shares/ownership after transaction: Not specified in the provided filing excerpt.
• Footnote: Options were granted pursuant to the 2020 Omnibus Equity Incentive Plan; grant and any exercise are exempt from Section 16(b) under Rule 16b-3(d).
• Timeliness: Filed on 2026-05-07 (same day as report date), i.e., appears timely.

Context
This was an equity compensation grant (options), which differs from an outright purchase or sale. Options grant the right to buy shares in the future if exercised; they do not necessarily indicate immediate buying or selling. Grants to directors are common as part of compensation or retention plans. The Rule 16b-3(d) exemption noted in the footnote means the short-swing profit rules under Section 16(b) do not apply to this grant/exercise as described.